National Institute of Allergy and Infectious Diseases, National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

NIAID Research Funding

NIAID Funding News
Opportunities and Announcements
Budget and Funding
Grants
Contracts
Standard Operating Procedures
What's an SOP?
Questions and Answers
Advisory Council
Glossary of Funding and Policy Terms
Find It! A-Z
Latest Updates
Search in Research Funding

This SOP is for grants only.

Standard Operating Procedure Table of Contents

Purpose

To ensure that institutions receiving an HHS grant for activities involving human subjects comply with federal, HHS, and NIAID regulations.

Procedure

NIH sets policies for human subjects research according to federal law 45 CFR 46, Protection of Human Subjects, which applies to all domestic and international grants. Find NIH policies in these documents:

Is the Project Human Subjects Research?

Before preparing a grant application, first determine whether your project qualifies as human subjects research.

Follow NIAID's Process for an Investigator-Initiated Clinical Trials

If you are proposing to conduct a clinical trial, follow NIAID's two-step approach for investigator-initiated clinical trials.

First, apply for a Clinical Trial Planning Grant -- R34; then, as an NIAID R34 recipient, you may be able to apply for the next step, a Clinical Trial Implementation Cooperative Agreement (U01). Read more in Investigator-Initiated Clinical Trials Resources and the Investigator-Initiated Clinical Trial Planning and Implementation Grants SOP.

Make sure you address protection of human subjects (risk, adequacy of protection against risks, potential benefits of the research to subjects, and importance of the knowledge gained), data and safety monitoring, and the inclusion of women, children, and minorities.

Inadequate protection or inclusion plans may negatively affect your priority score. See the PHS 398 instructions for more information.

If there is a scientific rationale for examining subpopulation differences in a foreign population, consider designing your study to accommodate those differences, and discuss inclusion of the groups in your application. For details, see NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.

Be aware of financial conflicts of interest. See Financial Relationships and Interests in Research Involving Human Subjects and the Financial Conflict of Interest for Awardees SOP. If you identify a conflict, find a way to reduce, eliminate, or manage it, and notify the chief grants management officer that you've taken those steps.

For more help in writing an application, read our How to Write a Human Subjects Grant Application tutorial.

Get Human Subjects Certification, a Federalwide Assurance, and Training

Your institution must obtain a Federalwide Assurance and register its institutional review board (IRB) or independent ethics committee (IEC) with the HHS Office for Human Research Protections. You must get IRB or IEC approval for your application.

You must also document training for investigators and key staff in the responsible conduct of clinical research.

Follow these links:

If You Get a Bar or Restriction

An application will receive a bar to award if the scientific review group is concerned about the protection of human subjects (a code 44 on the summary statement) -- see Human Subjects Involvement Codes.

It can also get a bar for unacceptable gender, minority, or children inclusion -- for a list of those codes, see Human Subjects Inclusion Codes.

At the end of the fiscal year, an application may get a restriction -- code 48 -- instead.

For details, read Bars to Grant Awards -- Human Subjects SOP.

Contacts

For grant questions, contact Cindy McDermott, cm550v@nih.gov, 301-594-7456.

For review questions, contact Hortencia Hornbeak, hhornbeak@niaid.nih.gov, 301-496-8208.

If you have knowledge to share or want more information on this topic, email deaweb@niaid.nih.gov with this link and your message. Thanks for helping us clarify and expand our knowledge base.

Links

Clinical Terms of Award at NIAID's Human Subjects Resources

Human Subjects SOP List

Trans NIAID Clinical Research Toolkit

NIH Guide Notices

Data and Safety Monitoring and Further Guidance for Phase I and II

Other

45 CFR 46, Protection of Human Subjects, HHS

Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not Individually Identifiable, FDA

Guidance on Research Involving Coded Private Information or Biological Specimens, OHRP

HHS Provides Guidance on Financial Relationships and Interests in Research Involving Human Subjects

Research Involving Human Subjects, NIH

Office of Biotechnology Activities, NIH

NIAID Clinical Terms of Award Restriction for China

NIH's Office of Extramural Research

NIH Grants Policy Statement, section on Human Subjects

Policies and Guidelines, HHS

Policy Guidance, OHRP

Protection of Human Subjects: Assurance Identification/IRB Certification/Declaration of Exemption form

Research Ethics Training Curriculum by Family Health International

Special Protections for Children as Research Subjects, OHRP

Privacy Act of 1974

Separator line
DHHS Logo Department of Health and Human Services NIH Logo National Institutes of Health NIAID Logo National Institute of Allergy and Infectious Diseases January 13, 2009
Home | Help | Site Index | Accessibility | Privacy Policy | Disclaimer | Web Site Links & Policies | FOIA